Evidence map›Paper›PMID 37159814›Full record

ArticleDrug and alcohol dependence reports2023

Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III.

L J Fields, W Roberts, I Schwing, M McCoy, T L Verplaetse, M R Peltier, R F Carretta, Y Zakiniaeiz, R Rosenheck, S A McKee

Open access · goldAbstract read
In one paragraph

Article in Drug and alcohol dependence reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

L J FieldsDepartment of Psychology, Arcadia University, 450 S Easton Rd, Glenside, PA 19038, United States.
W RobertsDepartment of Psychiatry, Yale School of Medicine, 300 George St #901, New Haven, CT 06511, United States.
I SchwingDepartment of Psychology, Arcadia University, 450 S Easton Rd, Glenside, PA 19038, United States.
M McCoyDepartment of Psychology, Arcadia University, 450 S Easton Rd, Glenside, PA 19038, United States.
T L VerplaetseDepartment of Psychiatry, Yale School of Medicine, 300 George St #901, New Haven, CT 06511, United States.
M R PeltierDepartment of Psychiatry, Yale School of Medicine, 300 George St #901, New Haven, CT 06511, United States.
R F CarrettaDepartment of Psychiatry, Yale School of Medicine, 300 George St #901, New Haven, CT 06511, United States.
Y ZakiniaeizDepartment of Psychiatry, Yale School of Medicine, 300 George St #901, New Haven, CT 06511, United States.
R RosenheckDepartment of Psychiatry, Yale School of Medicine, 300 George St #901, New Haven, CT 06511, United States.
S A McKeeDepartment of Psychiatry, Yale School of Medicine, 300 George St #901, New Haven, CT 06511, United States.
Yale University · USArcadia University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale-SCORE Resource Support CoreU54AA027989 · NIAAA · YALE UNIVERSITY · PI Sherry Ann McKee · 2020 to 2026
$13.0M
Behavioral and Neurochemical Mechanisms Underlying Stress-Precipitated DrinkingK01AA025670 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2018 to 2023
$882k
Sex Differences in Alcohol Use Disorder Neurodegeneration using Multimodal PET and DTI NeuroimagingK01AA029706 · NIAAA · YALE UNIVERSITY · PI Yasmin Zakiniaeiz · 2022 to 2026
$881k
Does endotoxin administration increase alcohol consumption in individuals with AUD?R03AA028361 · NIAAA · YALE UNIVERSITY · PI VERPLAETSE, TERRIL L · 2021 to 2022
$168k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS K01 AA025670NIAAA NIH HHS K01 AA029706NIAAA NIH HHS R03 AA028361NIAAA NIH HHS U54 AA027989
6 · The paper itself

Abstract

Background: Multimorbidity is linked to worse health outcomes than single health conditions. However, recent studies show that obesity may reduce the risk of developing substance use disorders (SUDs), particularly in vulnerable populations. We investigated how comorbid obesity and tobacco use disorder (TUD) relate to the risk of SUDs and psychiatric conditions. Methods: Data was used from 36,309 individuals who completed the National Epidemiological Survey on Alcohol and Related Conditions - Wave III. Individuals who met the DSM-5 criteria for TUD in the last year were defined as the TUD group. Obesity was defined as having a body mass index (BMI) greater than 30 kg/m Results: Controlling for demographic characteristics, we found that individuals with obesity including those individuals with TUD, had lower rates of comorbid SUD diagnosis than individuals with TUD alone. Additionally, individuals with combined TUD and obesity, and those with TUD alone, had the highest rates of comorbid psychiatric disorder diagnosis. Conclusions: The current study aligns with previous research suggesting that obesity may reduce risk of substance use disorders, even in individuals who have other risk factors promoting harmful substance use (e.g., tobacco use). These findings may inform targeted intervention strategies for this clinically relevant subpopulation.

Indexed as

MultimorbidityObesitySubstance use disorder (SUD)Tobacco use disorder (TUD)

Identifiers

PMID37159814
PMCPMC10163607
OpenAlexW4366778747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.